Direxion Daily S&P Biotech Bull 3X ETF
LABU
18 hedge funds and large institutions have $14.1M invested in Direxion Daily S&P Biotech Bull 3X ETF in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 11 reducing their positions, and 5 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.01% less ownership
Funds ownership: 0.45% → 0.44% (-0.01%)
5% less funds holding
Funds holding: 19 → 18 (-1)
16% less call options, than puts
Call options by funds: $31.7M | Put options by funds: $37.9M
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
42% less capital invested
Capital invested by funds: $24.5M → $14.1M (-$10.4M)
82% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$513K |
| 2 |
TCM
Traynor Capital Management
Malvern,
Pennsylvania
|
+$377K |
| 3 |
Walleye Trading
New York
|
+$56.1K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$35.5K |
| 5 |
CHP
Cable Hill Partners
Portland,
Oregon
|
+$8.25K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$7.14M |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4.3M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.81M |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$1.24M |
| 5 |
HJMC
Hellman Jordan Management Company
Quincy,
Massachusetts
|
-$1.03M |
LABU Hedge Fund Activity: Q3 2016 in Review
18 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) for Q3 2016, worth a combined $14.1M — down 42% from $24.5M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of LABU and 4 opened new positions — a net loss of 1 holder — while 11 trimmed existing stakes and 2 added.
The largest buyer was Virtu Financial, adding an estimated $513K. The largest seller was Jane Street, cutting an estimated $7.14M.
- 18 institutional investors held Direxion Daily S&P Biotech Bull 3X ETF (LABU) as of Q3 2016, down from 19 in Q2 2016.
- Funds reported $14.1M of Direxion Daily S&P Biotech Bull 3X ETF stock for Q3 2016, down 42% quarter-over-quarter.
- 4 funds opened new Direxion Daily S&P Biotech Bull 3X ETF positions in Q3 2016 and 5 closed out, a net change of -1 holder.
- The largest Direxion Daily S&P Biotech Bull 3X ETF buyer in Q3 2016 was Virtu Financial, an estimated $513K added.
- The largest Direxion Daily S&P Biotech Bull 3X ETF seller in Q3 2016 was Jane Street, an estimated $7.14M sold.
Based on aggregated 13F filings for Q3 2016.